Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell count, Red blood cell count increased, Red cell distribution width increased, Ultrasound scan
Clinical narrative: RBC, Hemoglobin, and Hct continue to elevate; RBC, Hemoglobin, and Hct continue to elevate; RBC, Hemoglobin, and Hct continue to elevate; CBC w/manual differential shows RDW - CV 22.9 % and RDW - SD 75.6 FL; 3 days after 2nd dose pain both legs from knee to bottom of both feet. Continuing still, today is day 6.; This is a spontaneous report from a contactable consumer (patient). A 77-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6208), dose 2 via an unspecified route of administration, administered in arm left on 20Mar2021 at 08:30 (at the age of 77-years-old) as dose 2, single; and patient previously took BNT162B2 (Lot Number: EN6198), dose 1 via an unspecified route of administration, administered in right arm on 25Feb2021 at 16:30 as dose 1, single for COVID-19 immunisation at other. Medical history included chronic obstructive pulmonary disease (COPD), Edema, Sleep Apnea, Irregular Heartbeat. And patient was allergic to ibuprofen and contrast dye. Concomitant medications included alendronate (FOSAMAX) 70 MG Oral Tablet Take 70 mg by mouth every 7 days. atorvastatin (LIPITOR) 20 MG Oral Table Take 1 tablet (20 mg total) by mouth at bedtime. calcium carbonate (TUMS) 500 MG Oral Chewable Tablet Chew 1 tablet three times daily. diltiazem (CARDIZEM) 60 MG Oral Tablet Take 1 tablet (60 mg total) by mouth twice daily. Fluticasone-Umeclidin-Vilant (TRELEGY ELLIPTA) 100-62.5-25 MCG/INH Inhalation Aerosol Powder, BREATH ACTIVATED Inhale 1 puff by mouth daily. furosemide (LASIX) 80 MG Oral Tablet Take 1 tablet (80 mg total) by mouth twice daily (8am/4pm) and Omeprazole 20 MG Oral Tablet Delayed Release Dispersible Take 20 mg by mouth daily. Prior to the vaccination, the patient was not diagnosed with COVID-19 and did not receive any other vaccines within four weeks. On 23Mar2021, after second dose, the patient experienced pain in legs and feet. Treated for symptoms and bloodwork shows abnormal red blood cells. Labs repeated CBC with automated differential, CBC with manual differential shows RDW - CV 22.9 percentage and RDW - SD 75.6 FL. RBC, Hemoglobin, and Hct (Haematocrit) continue to elevate. The patient has been referred to hematology. The reporter stated the events result in Doctor or other healthcare professional office/clinic visit. On an unspecified date in Mar2021, the patient underwent lab tests and procedures which included blood test: abnormal red blood cells, computerised tomogram: unknown results, full blood count: RDW - CV 22.9 % and RDW -SD 75.6 FL (w/manual differential), haematocrit: elevated, haemoglobin: elevated, magnetic resonance imaging: unknown results (lower extremity), neurological examination: unknown results, red blood cell count: Elevated and ultrasound scan: unknown results. Therapeutic measures were taken as a result of events include medication for leg pain (bloodwork, ultrasound, CT, neurological nerve study, MRI and lower extremity).  Since the vaccination, the patient had not been tested for COVID-19. It was reported there was no prolonged hospitalization. The outcome of the events was not resolved.